High-Risk Diabetic Maculopathy: Features and Management
A substantial group of patients with diabetic macular edema in our clinical practice is at high risk for profound and irreversible vision deterioration. Early identification of modifiable factors with long-term negative impact and their management, close monitoring and timely adjustments in the trea...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/78434 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1879164768269369344 |
|---|---|
| author | Pandova, Maya G. |
| author_browse | Pandova, Maya G. |
| author_facet | Pandova, Maya G. |
| author_sort | Pandova, Maya G. |
| building | IntechOpen |
| collection | Acceso abierto |
| description | A substantial group of patients with diabetic macular edema in our clinical practice is at high risk for profound and irreversible vision deterioration. Early identification of modifiable factors with long-term negative impact and their management, close monitoring and timely adjustments in the treatment can significantly reduce the probability of visual disability in the individual patient. This approach can also provide important guidelines for proactive decision making in order to avoid the risk of suboptimal response and unsatisfactory outcome. |
| doi_str_mv | 10.5772/intechopen.99748 |
| first_indexed | 2026-10-15T21:39:35Z |
| format | Book Chapter |
| fullrecord | <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>intech-78434</identifier><datestamp>2021-09-05</datestamp>
<dc:title>High-Risk Diabetic Maculopathy: Features and Management</dc:title>
<dc:creator>Maya G. Pandova</dc:creator>
<dc:subject>Health Sciences</dc:subject>
<dc:description>A substantial group of patients with diabetic macular edema in our clinical practice is at high risk for profound and irreversible vision deterioration. Early identification of modifiable factors with long-term negative impact and their management, close monitoring and timely adjustments in the treatment can significantly reduce the probability of visual disability in the individual patient. This approach can also provide important guidelines for proactive decision making in order to avoid the risk of suboptimal response and unsatisfactory outcome.</dc:description>
<dc:publisher>IntechOpen</dc:publisher>
<dc:date>2021-09-05</dc:date>
<dc:type>Chapter, Part Of Book</dc:type>
<dc:identifier>https://www.intechopen.com/chapters/78434</dc:identifier>
<dc:identifier>doi:10.5772/intechopen.99748</dc:identifier>
<dc:language>en</dc:language>
<dc:relation>ISBN:978-1-83969-764-7</dc:relation>
<dc:rights>https://creativecommons.org/licenses/by/3.0/</dc:rights>
<dc:source>https://www.intechopen.com/books/11039 ; Diabetic Eye Disease - From Therapeutic Pipeline to the Real World</dc:source>
</oai_dc:dc> |
| id | intech-78434 |
| institution | IntechOpen |
| isbn | 978-1-83969-764-7 |
| language | English |
| last_indexed | 2026-10-15T21:39:35Z |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | IntechOpen |
| publisherStr | IntechOpen |
| record_format | oai_dc |
| spelling | intech-784342021-09-05 High-Risk Diabetic Maculopathy: Features and Management Maya G. Pandova Health Sciences A substantial group of patients with diabetic macular edema in our clinical practice is at high risk for profound and irreversible vision deterioration. Early identification of modifiable factors with long-term negative impact and their management, close monitoring and timely adjustments in the treatment can significantly reduce the probability of visual disability in the individual patient. This approach can also provide important guidelines for proactive decision making in order to avoid the risk of suboptimal response and unsatisfactory outcome. IntechOpen 2021-09-05 Chapter, Part Of Book https://www.intechopen.com/chapters/78434 doi:10.5772/intechopen.99748 en ISBN:978-1-83969-764-7 https://creativecommons.org/licenses/by/3.0/ https://www.intechopen.com/books/11039 ; Diabetic Eye Disease - From Therapeutic Pipeline to the Real World |
| spellingShingle | Health Sciences Pandova, Maya G. High-Risk Diabetic Maculopathy: Features and Management |
| title | High-Risk Diabetic Maculopathy: Features and Management |
| title_full | High-Risk Diabetic Maculopathy: Features and Management |
| title_fullStr | High-Risk Diabetic Maculopathy: Features and Management |
| title_full_unstemmed | High-Risk Diabetic Maculopathy: Features and Management |
| title_short | High-Risk Diabetic Maculopathy: Features and Management |
| title_sort | high risk diabetic maculopathy features and management |
| topic | Health Sciences |
| url | https://www.intechopen.com/chapters/78434 |
| work_keys_str_mv | AT pandovamayag highriskdiabeticmaculopathyfeaturesandmanagement |